These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20602288)

  • 1. Pituitary adenomas and craniopharyngiomas are CDX2 negative neoplasms.
    Schittenhelm J; Psaras T; Meyermann R; Honegger J; Beschorner R
    Folia Neuropathol; 2010; 48(2):75-80. PubMed ID: 20602288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Expression of Stem Cell Markers in Human Adamantinomatous Craniopharyngioma and Pituitary Adenoma.
    Chang CV; Araujo RV; Cirqueira CS; Cani CM; Matushita H; Cescato VA; Fragoso MC; Bronstein MD; Zerbini MC; Mendonca BB; Carvalho LR
    Neuroendocrinology; 2017; 104(2):183-193. PubMed ID: 27161333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of homeodomain protein CDX2 in colorectal adenoma and adenocarcinoma.
    Bakaris S; Cetinkaya A; Ezberci F; Ekerbicer H
    Histol Histopathol; 2008 Sep; 23(9):1043-7. PubMed ID: 18581275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
    Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
    Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product.
    Sanno N; Teramoto A; Matsuno A; Osamura RY
    Arch Pathol Lab Med; 1996 Jan; 120(1):73-7. PubMed ID: 8554449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.
    McDonald WC; McDonald KN; Helmer JA; Ho B; Wang A; Banerji N
    Arch Pathol Lab Med; 2021 May; 145(5):592-598. PubMed ID: 32991684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
    Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
    J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of CDX2 expression in normal choroid plexus epithelium and choroid plexus tumors.
    Beschorner R; Mittelbronn M; Mugler M; Meyermann R; Schittenhelm J
    Histol Histopathol; 2009 Dec; 24(12):1507-14. PubMed ID: 19795349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from rathke cleft cyst.
    Xin W; Rubin MA; McKeever PE
    Arch Pathol Lab Med; 2002 Oct; 126(10):1174-8. PubMed ID: 12296753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas.
    Cao J; Lin JP; Yang LX; Chen K; Huang ZS
    Br J Neurosurg; 2010 Jun; 24(3):249-56. PubMed ID: 20128632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
    Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
    Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonectin expression in surrounding stroma of craniopharyngiomas: association with recurrence rate and brain infiltration.
    Ebrahimi A; Honegger J; Schluesener H; Schittenhelm J
    Int J Surg Pathol; 2013 Dec; 21(6):591-8. PubMed ID: 23648679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New aspects of tumor pathology of the pituitary].
    Saeger W
    Pathologe; 2015 May; 36(3):293-300. PubMed ID: 25947224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prop-1 gene expression in human pituitary tumors.
    Nakamura S; Ohtsuru A; Takamura N; Kitange G; Tokunaga Y; Yasunaga A; Shibata S; Yamashita S
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2581-4. PubMed ID: 10404841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of proliferating cell nuclear antigen in craniopharyngioma and tumor recurrence].
    Pan J; Qi ST; Deng YJ; Ding YQ; Peng L; Li XQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):363-5. PubMed ID: 12390748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial and organ-related marker expression in pituitary adenomas.
    Cykowski MD; Takei H; Baskin DS; Rivera AL; Powell SZ
    Neuropathology; 2016 Aug; 36(4):354-64. PubMed ID: 26991787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI.
    Choi SH; Kwon BJ; Na DG; Kim JH; Han MH; Chang KH
    Clin Radiol; 2007 May; 62(5):453-62. PubMed ID: 17398271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
    Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R
    Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt4 is overexpressed in human pituitary adenomas and is associated with tumor invasion.
    Li W; Zhang Y; Zhang M; Huang G; Zhang Q
    J Clin Neurosci; 2014 Jan; 21(1):137-41. PubMed ID: 24200887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.